{"version":"1.0","type":"link","title":"Adverse Reactions of First-Line Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma Treatment: A Descriptive Analysis From WHO-VigiAccess.","author_name":"Sui WF 외","author_url":"https://prs-insight.online/author/Sui%20WF","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/118945","thumbnail_width":1200,"thumbnail_height":630}